Publish Ahead of Print - Chinese Clinical Oncology

The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.

Original Article

Dural metastases in breast cancer: progression pattern, treatment and prognosis—a single center experience

Yujie Wang, Yimin Han, Yanzhao Yang, Cheng Xu

Published online: 02 December 2024

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Editorial Commentary

Is metastasis-directed local therapy the new standard of care for patients with oligometastasic esophageal squamous cell carcinoma?—a perspective on the ESO-Shanghai 13 Trial

Neil B. Newman, Krishan R. Jethwa

Published online: 17 October 2024

PDF Peer Review File COI Form Open Access

Editorial Commentary

Befotertinib in first-line treatment for Chinese non-small cell lung cancer patients harboring common EGFR-mutations reveals similar efficacy to other third-generation EGFR-TKIs but somewhat different safety profile

Jens Benn Sørensen, Eric Santoni-Rugiu, Edyta Maria Urbanska

Published online: 21 August 2024

PDF Peer Review File COI Form Open Access

Editorial Commentary

Benefit from addition of local therapy in oligometastatic oesophageal squamous cell carcinoma

Yuvnik Trada, Fiona Day, Jarad Martin

Published online: 21 August 2024

PDF Peer Review File COI Form Open Access

Editorial Commentary

Befotertinib: one more drug targeting EGFR—the more may be the merrier

Guilherme Sacchi de Camargo Correia, Yanyan Lou, Rami Manochakian

Published online: 13 August 2024

PDF Peer Review File COI Form Open Access

Editorial Commentary

Artificial intelligence assistance during upper endoscopy: a game changer in detection of esophageal squamous cell carcinoma?

Annemijn D. I. Maan, Arjun D. Koch

Published online: 18 July 2024

PDF Peer Review File COI Form Open Access